Sign in
CompletedNo phase

Magnesium Oxide and Letrozole Versus Letrozole Alone on Ovarian Response in Insulin Resistant PCOS

Key facts

Who runs it
Bangladesh Medical University
Where
Bangladesh1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
60 people enrolled
Started
1 Jun 2025
Ended
28 May 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Experimental drug: Magnesium oxide (365 mg)
  • Letrozole 2.5mg
Record updated
14 August 2026

Who can take part

Age
18 years to 35 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • All PCOS patients who fulfill the Rotterdam diagnostic criteria
  • Primary or secondary subfertility
  • Women of age: 18-35yr
  • Insulin resistance (HOMA-IR>2) (Hydrie et al.,2012)

Who cannot take part

  • Male factor; Uterine, tubal and endometrial factor; Pelvic inflammatory disease; Patient with other endocrine disease like hypothyroidism, hyperthyroidism, congenital adrenal hyperplasia, Diabetes mellitus and hyperprolactinemia; BMI less than 18.5 or more than 30; Known allergy to magnesium oxide; Any medication in the last 3 months which would affect insulin resistance (metformin, myoinositol); Conditions with a high risk for hypomagnesemia such as using diuretics, alcoholism, persistent diarrhoea

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Does pretreatment with magnesium oxide followed by letrozole increase ovulation rate? What medical problems do participants have when taking drug magnesium oxide and letrozole? Researchers will compare magnesium oxide and letrozole to letrozole alone to see pretreatment with magnesium oxide followed by letrozole works better as ovulation induction.

Read full original descriptionShow less

Experimental group will receive magnesium oxide and letrozole alone. Comparator group will receive letrozole alone.

The 2 groups in the trial

  • Experimental arm: Magnesium oxide and letrozoleTreatment being tested

    Participants will receive tab magnesium oxide 365mg twice daily for 3months followed by tab letrozole 2.5mg 3 tablets daily at night from 2nd to 6th day of menstruation.

    Treatment: Experimental drug: Magnesium oxide (365 mg)

  • Comparator group: LetrozoleExisting treatment, for comparison

    Participants will receive 2.5mg of letrozole, 3 tablets at night from 2nd to 6th day of menstruation.

    Treatment: Letrozole 2.5mg

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Pretreatment With Magnesium Oxide Followed by Letrozole on Ovarian Response in Subfertile Women With Insulin Resistant Polycystic Ovarian Syndrome in Comparison to Letrozole Alone
Record updated
14 August 2026